NR2E3 and acute myeloid leukemia: We show a positive correlation between increased RNR expression and proliferative malignancy in patients with AML in this study, and MB potently inhibits RNR activity by targeting the RRM2 protein and thereby blocks DNA synthesis and the malignant proliferation of AML cells in vitro and in vivo.